Correction: Correlative Gene Expression to Protective Seroconversion In Rift Valley Vaccinates. by Richard C Laughin, Kenneth L Drake, John C Morrill, L Garry Adams

Get full text

Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA. by John C Morrill, Tetsuro Ikegami, Naoko Yoshikawa-Iwata, Nandadeva Lokugamage, Sungyong Won, Kaori Terasaki, Aya Zamoto-Niikura, C J Peters, Shinji Makino

Get full text

Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania by Salama Nyundo, Ester Adamson, Jessica Rowland, Pedro M. Palermo, Mirende Matiko, George E. Bettinger, Philemon Wambura, John C. Morrill, Douglas M. Watts

Get full text

Correction: Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA. by John C. Morrill, Tetsuro Ikegami, Naoko Yoshikawa-Iwata, Nandadeva Lokugamage, Sungyong Won, Kaori Terasaki, Aya Zamoto-Niikura, C. J. Peters, Shinji Makino

Get full text

Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model. by Tetsuro Ikegami, Aaron Balogh, Shoko Nishiyama, Nandadeva Lokugamage, Tais B Saito, John C Morrill, Vinay Shivanna, Sabarish V Indran, Lihong Zhang, Jennifer K Smith, David Perez, Terry L Juelich, Igor Morozov, William C Wilson, Alexander N Freiberg, Juergen A Richt

Get full text

Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile by Thomas P. Monath, Jeroen Kortekaas, Douglas M. Watts, Rebecca C. Christofferson, Angelle Desiree LaBeaud, Brian B Gowen, Clarence J. Peters, Darci R. Smith, Robert Swanepoel, John C. Morrill, Thomas G. Ksiazek, Phillip R Pittman, Stuart T. Nichol, Brian H. Bird, George Bettinger

Get full text